MedPath

High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women

Phase 3
Completed
Conditions
Body Mass Index Quantitative Trait Locus 8 Disorder
Tangier Disease
Interventions
Other: nutrition intervention
Registration Number
NCT01763528
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

The investigators aimed to determine the effects of HP diet on CVD risk factors and hs-CRP among overweight and obese women.

Detailed Description

Background: Studies regarding the effects of high protein (HP) diet on cardiovascular (CVD) risk factors have reported contradictory results.

Objective: In present study, we aimed to determine the effects of HP diet on CVD risk factors and hs-CRP among overweight and obese women.

Design: In this randomized controlled trial, we recruited 60 overweight and obese women, aged 20-65 years into HP or control energy restricted diets for three months (protein, carbohydrate, fat: 25%, 45%, 30% vs. 15%, 55%, 30%, respectively). Total protein amount, divided to animal and plant sources in 50%-50% and animal sources distributed (half/half) between meats and dairy products. Fasting blood samples, hs-CRP, lipid profile, systolic and diastolic blood pressure and anthropometric measurements were measured based on the standard guidelines.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
63
Inclusion Criteria
  • women aged between 20-65 years
  • BMI > 25 kg/m2
  • were no smoker
  • no history of renal, liver, metabolic diseases or type 1 or 2 diabetes
Exclusion Criteria
  • had gastrointestinal, respiratory, cardiovascular, metabolic, liver and renal -diseases
  • had macroalbuminuria
  • were pregnancy or lactating

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nutrition interventionnutrition interventionhigh protein diet
Primary Outcome Measures
NameTimeMethod
the amount of weight reduction in two dietary groups3 months

weight reduction (kg)

Secondary Outcome Measures
NameTimeMethod
LDL-C (mg/dl3 months

measurement of LDL-C (mg/dl), HDL-C (mg/dl), total cholesterol (mg/dl), fasting blood glucose (mg/dl), systolic and diastolic blood pressure (mmHg), c reactive protein by the measurement of blood samples.

HDL-C (mg/dl)3 months
total cholesterol (mg/dl)3 months
fasting blood glucose(mg/dl)3 months
blood pressure (mmHg)3 months
C-reactive protein (mc/dl)3 months
© Copyright 2025. All Rights Reserved by MedPath